Cargando…
A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators
BACKGROUND: Mitochondria are highly dynamic organelles whose morphology and position within the cell is tightly coupled to metabolic function. There is a limited list of essential proteins that regulate mitochondrial morphology and the mechanisms that govern mitochondrial dynamics are poorly underst...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919466/ https://www.ncbi.nlm.nih.gov/pubmed/20659315 http://dx.doi.org/10.1186/1741-7007-8-100 |
_version_ | 1782185188559683584 |
---|---|
author | Schauss, Astrid C Huang, Huiyan Choi, Seok-Yong Xu, Liqun Soubeyrand, Sébastien Bilodeau, Patricia Zunino, Rodolfo Rippstein, Peter Frohman, Michael A McBride, Heidi M |
author_facet | Schauss, Astrid C Huang, Huiyan Choi, Seok-Yong Xu, Liqun Soubeyrand, Sébastien Bilodeau, Patricia Zunino, Rodolfo Rippstein, Peter Frohman, Michael A McBride, Heidi M |
author_sort | Schauss, Astrid C |
collection | PubMed |
description | BACKGROUND: Mitochondria are highly dynamic organelles whose morphology and position within the cell is tightly coupled to metabolic function. There is a limited list of essential proteins that regulate mitochondrial morphology and the mechanisms that govern mitochondrial dynamics are poorly understood. However, recent evidence indicates that the core machinery that governs mitochondrial dynamics is linked within complex intracellular signalling cascades, including apoptotic pathways, cell cycle transitions and nuclear factor kappa B activation. Given the emerging importance of mitochondrial plasticity in cell signalling pathways and metabolism, it is essential that we develop tools to quantitatively analyse the processes of fission and fusion. In terms of mitochondrial fusion, the field currently relies upon on semi-quantitative assays which, even under optimal conditions, are labour-intensive, low-throughput and require complex imaging techniques. RESULTS: In order to overcome these technical limitations, we have developed a new, highly quantitative cell-free assay for mitochondrial fusion in mammalian cells. This assay system has allowed us to establish the energetic requirements for mitochondrial fusion. In addition, our data reveal a dependence on active protein phosphorylation for mitochondrial fusion, confirming emerging evidence that mitochondrial fusion is tightly integrated within the global cellular response to signaling events. Indeed, we have shown that cytosol derived from cells stimulated with different triggers either enhance or inhibit the cell-free fusion reaction. CONCLUSIONS: The adaptation of this system to high-throughput analysis will provide an unprecedented opportunity to identify and characterize novel regulatory factors. In addition, it provides a framework for a detailed mechanistic analysis of the process of mitochondrial fusion and the various axis of regulation that impinge upon this process in a wide range of cellular conditions. See Commentary: http://www.biomedcentral.com/1741-7007/8/99 |
format | Text |
id | pubmed-2919466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29194662010-08-11 A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators Schauss, Astrid C Huang, Huiyan Choi, Seok-Yong Xu, Liqun Soubeyrand, Sébastien Bilodeau, Patricia Zunino, Rodolfo Rippstein, Peter Frohman, Michael A McBride, Heidi M BMC Biol Methodology Article BACKGROUND: Mitochondria are highly dynamic organelles whose morphology and position within the cell is tightly coupled to metabolic function. There is a limited list of essential proteins that regulate mitochondrial morphology and the mechanisms that govern mitochondrial dynamics are poorly understood. However, recent evidence indicates that the core machinery that governs mitochondrial dynamics is linked within complex intracellular signalling cascades, including apoptotic pathways, cell cycle transitions and nuclear factor kappa B activation. Given the emerging importance of mitochondrial plasticity in cell signalling pathways and metabolism, it is essential that we develop tools to quantitatively analyse the processes of fission and fusion. In terms of mitochondrial fusion, the field currently relies upon on semi-quantitative assays which, even under optimal conditions, are labour-intensive, low-throughput and require complex imaging techniques. RESULTS: In order to overcome these technical limitations, we have developed a new, highly quantitative cell-free assay for mitochondrial fusion in mammalian cells. This assay system has allowed us to establish the energetic requirements for mitochondrial fusion. In addition, our data reveal a dependence on active protein phosphorylation for mitochondrial fusion, confirming emerging evidence that mitochondrial fusion is tightly integrated within the global cellular response to signaling events. Indeed, we have shown that cytosol derived from cells stimulated with different triggers either enhance or inhibit the cell-free fusion reaction. CONCLUSIONS: The adaptation of this system to high-throughput analysis will provide an unprecedented opportunity to identify and characterize novel regulatory factors. In addition, it provides a framework for a detailed mechanistic analysis of the process of mitochondrial fusion and the various axis of regulation that impinge upon this process in a wide range of cellular conditions. See Commentary: http://www.biomedcentral.com/1741-7007/8/99 BioMed Central 2010-07-26 /pmc/articles/PMC2919466/ /pubmed/20659315 http://dx.doi.org/10.1186/1741-7007-8-100 Text en Copyright ©2010 Schauss et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Article Schauss, Astrid C Huang, Huiyan Choi, Seok-Yong Xu, Liqun Soubeyrand, Sébastien Bilodeau, Patricia Zunino, Rodolfo Rippstein, Peter Frohman, Michael A McBride, Heidi M A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators |
title | A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators |
title_full | A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators |
title_fullStr | A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators |
title_full_unstemmed | A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators |
title_short | A novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators |
title_sort | novel cell-free mitochondrial fusion assay amenable for high-throughput screenings of fusion modulators |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919466/ https://www.ncbi.nlm.nih.gov/pubmed/20659315 http://dx.doi.org/10.1186/1741-7007-8-100 |
work_keys_str_mv | AT schaussastridc anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT huanghuiyan anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT choiseokyong anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT xuliqun anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT soubeyrandsebastien anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT bilodeaupatricia anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT zuninorodolfo anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT rippsteinpeter anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT frohmanmichaela anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT mcbrideheidim anovelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT schaussastridc novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT huanghuiyan novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT choiseokyong novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT xuliqun novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT soubeyrandsebastien novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT bilodeaupatricia novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT zuninorodolfo novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT rippsteinpeter novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT frohmanmichaela novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators AT mcbrideheidim novelcellfreemitochondrialfusionassayamenableforhighthroughputscreeningsoffusionmodulators |